Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Crinetics Pharmaceuticals
(CRNX) Q2 2024
Earnings
CRNX
May 9
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.01
-0.94
-0.88
-0.81
Details
Expected EPS
-0.809582
Actual EPS
-0.93
Surprise EPS
-0.12
Surprise Percent
-14.87%
Description
Crinetics Pharmaceuticals (CRNX) has reported earnings of -0.93 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login